1Birkeland KI,Kilhovd B, Thorsby P,et al. Heterogeneity of nonlinsuin-dependent diabetes expressed as vatiability in insulin sensitivity,beta-cell ruction and cardiovascular risk profile. Diabet Med, 2003,20(1) : 37-45.
2Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med,1996,335:1001-1009.
1Assmann G,Schulte H.Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease(the PROCAM experience)[J].Am J Cardiol,1992,70:733.
2Lamendola C.Hypertriglyceridemia and low high-density lipoprotein:risks for coronary artery disease?[J].J Cardiovasc Nurs,2001,14:79.
3Jeppesen J,Hein Ho,Suadicani P,et al.Triglyceride concentration and ischemic heart disease:an eight-year follow up in the Copenhagen male study[J].Circulation,1998,97:1209.
4Gotto AM.Triglyceride as a risk factor for coronary artery disease[J].Am J Cardiol,1998,82:22.
4Sit D, Kadiroglu AK, Yimaz ME. The prevalence ot insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients[J]. Renal Failure, 2005,27 (4) : 403-407.
5Diez JJ, Iglesias P, Fernandez-Reyes MJ, et al. Serum concentration of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with endstage renal diseases[J]. Clin Endocrinol, 2005, 62 (3) . 242-249.
8Fliser D,Kielstein JT,Menne J. Insulin resistance and renal disease[J].Contrib Nephrol, 2006, 151 (3): 203- 211.
9Savage DB,Petersen KF , Shulman G. Disordered lipid metabolism and the pathogenesis of insulin resistance [J]. Physiol Rev, 2007,87 (2): 507-520.
10Diez J J, Iglesias P, Fernandez-Reyes M J, et al. Serum concentrations of leptin, adiponectin and resistin and their relationship with cardiovascular disease in patients with end stage renal disease[J].Clin Endocrinol,2005, 62(2): 242-249.
